The Directors Team at Taysha Gene Therapies comprises senior leaders overseeing critical aspects of the company, from regulatory affairs and clinical operations to translational sciences and business development. This team's collaborative efforts ensure the rapid progression of curative treatments from research to patient care, while managing corporate communications, investor relations, and overall business strategy to fulfill their mission of eradicating severe monogenic CNS diseases.
Berge Minassian
Director
Carol Lutz
Business Operations Director
Emdadul Haque, Ph.D.
Sr. Director Of Translational ...
Hayleigh Collins
Director, Head Of Corporate Co...
Kathy Reape
Director
Laura Sepp-Lorenzino
Director
Patrick Nolan
Director, Business Development...
Phillip Donenberg
Director
Steven Gray
Director
Sukumar Nagendran
Director